Clinical Trial Update: A Phase I/II Study of AGA111 for Lumbar Interbody Fusion in Patients With Degenerative Disc Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for AGA111 in lumbar interbody fusion for degenerative disc disease has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• AGA111

Snippet

Sponsor: Angitia Biopharmaceuticals | Conditions: Degenerative Disc Disease | Phase 1, Phase 2 | Status: COMPLETED